Alliance to Promote Sedation Management

A strategic alliance to introduce new sedation management technology to interventional and specialty medical markets around the world has been announced by Boston Scientific Corp. (Natick, MA, USA) and Aspect Medical Systems (Newton, MA, USA).

The alliance will focus on the development and distribution of brain monitoring technology specifically designed to improve the safety, efficiency, and delivery of sedation to patients undergoing less-invasive medical procedures. Aspect has pioneered the monitoring of consciousness with its Bispectral Index (BIS) technology and will lead the development of new products designed especially for the specialty procedures market.
This market includes gastrointestinal endoscopy, interventional cardiology, and interventional radiology. Boston Scientific will provide marketing and distribution channels for the new products.

Under the terms of the alliance, Boston Scientific has made an equity investment of US$10 million in Aspect Medical, while Aspect has given Boston Scientific an option right for worldwide distribution of the new technology designed for the specialty procedures market.

"By combining Boston Scientific's market knowledge with Aspect's technology expertise, we believe we will be well-positioned to bring an important technology to market that will help clinicians enhance the quality, safety, and efficiency of the administration of sedatives during less-invasive procedures,” said Dr. Henry Tung, anesthesiologist and vice president of Boston Scientific.




Related Links:
Boston Scientific
Aspect